Navigation Links
Gene therapy for metastatic melanoma in mice produces complete remission
Date:11/18/2010

INDIANAPOLIS A potent anti-tumor gene introduced into mice with metastatic melanoma has resulted in permanent immune reconfiguration and produced a complete remission of their cancer, according to an article to be published in the December 2010 issue of the Journal of Clinical Investigation. The online version is now available.

Indiana University School of Medicine researchers used a modified lentivirus to introduce a potent anti-melanoma T cell receptor gene into the hematopoietic stem cells of mice. Hematopoietic stem cells are the bone marrow cells that produce all blood and immune system cells.

The T cell gene, which recognizes a specific protein found on the surface of melanoma, was isolated and cloned from a patient with melanoma. The gene-modified stems cells were then transplanted back into hosts and found to eradicate metastatic melanoma for the lifetime of the mice.

"We found that the transplantation of gene-modified hematopoietic stem cells results in a new host immune system and the complete elimination of tumor," reported Christopher E. Touloukian, M.D., an assistant professor of surgery and immunology at the IU School of Medicine and a member of the Indiana University Melvin and Bren Simon Cancer Center. "To date, cancer immunotherapies have been hampered by limited and diminishing immune responses over time. We believe this type of translational model opens new doors for patients with melanoma and potentially other cancers by taking advantage of the potent regenerative capacity of hematopoietic stem cells and new advances in gene therapy."

This research was funded by a National Institutes of Health grant.

It has paved the way for a new clinical trial in humans funded by the V Foundation for Cancer Research. The pilot phase I trial will involve treatment of 12 patients and focus primarily on the safety and efficacy of the therapy, said Dr. Touloukian, who is the senior author on the JCI pa
'/>"/>

Contact: Mary L. Hardin
mhardin@iupui.edu
317-274-7722
Indiana University School of Medicine
Source:Eurekalert  

1

GOOD

Page: 1 2

Related medicine news :

1. Neuralstem files FDA application for first drug therapy
2. Combination therapy improves survival time for patients with advanced liver cancer
3. Gene Therapy Shows Potential Against Heart Failure
4. Hearing loss common following radiation therapy for head and neck cancer
5. Targeted therapy reactivates guardian of the genome in resistant cancer
6. GUMC: fMRI predicts outcome to talk therapy in children with an anxiety disorder
7. Colorectal cancer risk increases in prostate cancer patients on androgen deprivation therapy
8. Fracture Risk Seen With Hormone Therapy for Prostate Cancer
9. Menopausal hormone therapy may increase risk of ovarian cancer
10. Side effects of hormonal breast cancer therapy increased; may affect treatment adherence
11. Potential drug therapy for diabetic retinopathy under study
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Gene therapy for metastatic melanoma in mice produces complete remission
(Date:5/25/2013)... 2013 Dr. Farooq Ashraf, founder of ... Dubai, has announced his practice’s adoption of The iFS ... FDA-cleared femtosecond laser proven with more than 10 years ... of LASIK. , “We are happy to announce that ... at our Dubai LASIK practice,” Ashraf said Thursday. “We ...
(Date:5/25/2013)... May 25, 2013 IBISWorld estimates that revenue ... an average annual rate of 28.7% to $1.0 billion in ... 2013. From 2002 and 2008, no new cell therapy products ... relatively modest growth during that period. In the years since, ... new products. This factor contributed to the industry's fast growth ...
(Date:5/25/2013)... Ayurveda is the traditional medicine of India. Translated from ... a medical science, its scope enters into the realms of ... is that disease is the end result of living out ... to re-establish optimal health, we must discover where we are ... which brings us back into harmony. , The California College ...
(Date:5/25/2013)... http://www.resource4thepeople.com/defectivedrugs/Actos-Bladder-Cancer-Lawsuit.html , Resource4thePeople is ... of a jury's award of $6.5 million in damages ... the country over allegations that the diabetes drug Actos ... The judge in the case ruled that the man's ... was caused by the medication.** , Bloomberg News in ...
(Date:5/24/2013)... A recent study by research group Harris Interactive found that ... season. Almost 138 million people are fearful of pulling on ... issues and a quarter admit they feel pressured to lose ... those anxious about their size consider the over the counter ... effort to improve diet and exercise habits ahead of peak ...
Breaking Medicine News(10 mins):Health News:Atlanta Vision Clinic Acquires the Latest in Blade-Free Lasik Technology Bringing Dubai Patients the Intralase Method 2Health News:Slow Healing: Cell Therapy in the US Industry Market Research Report Now Available from IBISWorld 2Health News:Slow Healing: Cell Therapy in the US Industry Market Research Report Now Available from IBISWorld 3Health News:Ayurveda Education Programs Offered by the California College of Ayurveda Include Panchakarma Certification, Practitioner Courses, and Body Therapy Classes 2Health News:Alleged Actos Bladder Cancer Lawsuits Update: $6.5 Million Verdict Overturned as Resource4thePeople Attorneys Continue to Accept Cases 2Health News:Alleged Actos Bladder Cancer Lawsuits Update: $6.5 Million Verdict Overturned as Resource4thePeople Attorneys Continue to Accept Cases 3Health News:Alleged Actos Bladder Cancer Lawsuits Update: $6.5 Million Verdict Overturned as Resource4thePeople Attorneys Continue to Accept Cases 4Health News:PhenObestin 37.5 Can Help Make Bathing Suit Season Less Stressful 2Health News:PhenObestin 37.5 Can Help Make Bathing Suit Season Less Stressful 3
... survival rates for patients receiving heart, liver and ... averages at statistically significant levels, according to new ... Recipients (SRTR). , Released on January ... each transplant program at all facilities in the ...
... these side effects are rare and benefits still outweigh ... -- Cholesterol-lowering statins could raise the risk for tendon ... that statin-attributed tendinous complications are rare, considering the huge ... Hospital. , Reporting in the March issue of ...
... Stiefel Laboratories, Inc.,has announced the promotion of William D. ... board of directors,elected Humphries to the position at its ... the organization,s 160-year history that a,non-family member has held ... to the board,s trust in Bill,s proven,ability to serve ...
... damage begins at blood sugar levels below current threshold ... News) -- Fasting blood sugar levels are typically used ... disease that can lead to blindness begins at blood ... report. , Retinopathy is a vascular condition where the ...
... University College of Nursing (NYUCN), has received an eight-year, $4.1 ... study newly licensed registered nurses (NLRNs) in order to track ... to 10 the number of years these nurses will be ... cohorts of NLRNs and to survey new nurses about the ...
... NEW YORK, Feb. 29 Philips Electronics (PHG) on ... its kind, during,a media tour of the new Mercy ... doors on March 16., , (See video from ... The canvas, displayed in the Women,s and Children,s waiting ...
Cached Medicine News:Health News:Survival rates exceed national averages for UCSF heart, liver and lung transplant programs 2Health News:Cholesterol-Lowering Statins Tied to Tendon Woes 2Health News:Cholesterol-Lowering Statins Tied to Tendon Woes 3Health News:Stiefel Laboratories, Inc. Appoints New President 2Health News:Marker for Diabetes Might Miss Early Vision Complication 2Health News:NYU College of Nursing researcher awarded $4.1M grant to study nurses' work decisions 2Health News:VIDEO from Medialink and Philips: Philips Electronics Unveils First 'Imagination Light Canvas' at the New Mercy Medical Center in Rogers AR 2
(Date:5/24/2013)... Colo. , May 24, 2013  Heska Corporation (NASDAQ: ... diagnostic and specialty products, announced today that Dr. ... officer, and Jason Napolitano , executive vice ... Annual Marcum MicroCap Conference, which is being held May 30, ... the Grand Hyatt Hotel. The Company,s presentation ...
(Date:5/24/2013)... The potential of the pulmonary route as ... has been receiving undeniable attention with the recent advances ... crucial formulation considerations for orally inhaled products together with ... in the efficiency of pulmonary delivery, and great strides ... techniques and devices in recent years. With ...
(Date:5/23/2013)... , May 23, 2013 Neurocrine Biosciences, Inc. ... Kevin Gorman , President and Chief Executive Officer of ... th Annual dbAccess Health Care Conference in Boston.   ... 30 at 11:20 a.m. Eastern Time / 8:20 a.m. Pacific ... on the Company,s website at http://www.neurocrine.com . ...
Breaking Medicine Technology:Heska Corporation To Present At The Second Annual Marcum LLP MicroCap Conference 2Inhalaltion Drug Delivery: 11-12 September - Berlin, Germany 2
... (Nasdaq: IDIX ) announced today that Idenix management ... Small Cap Healthcare Conference on Tuesday, September 14, 2010 at ... City and at the Stifel Nicolaus Healthcare Conference on Thursday, ... Seasons Hotel, Boston. The live and archived ...
... YORK, Sept. 7 Reportlinker.com announces that a ... catalogue: Cell Therapy - Technologies, ... SummaryThis report describes ... have already started to play an important role ...
Cached Medicine Technology:Reportlinker Adds Cell Therapy - Technologies, Markets and Companies 2Reportlinker Adds Cell Therapy - Technologies, Markets and Companies 3Reportlinker Adds Cell Therapy - Technologies, Markets and Companies 4Reportlinker Adds Cell Therapy - Technologies, Markets and Companies 5Reportlinker Adds Cell Therapy - Technologies, Markets and Companies 6Reportlinker Adds Cell Therapy - Technologies, Markets and Companies 7Reportlinker Adds Cell Therapy - Technologies, Markets and Companies 8Reportlinker Adds Cell Therapy - Technologies, Markets and Companies 9Reportlinker Adds Cell Therapy - Technologies, Markets and Companies 10Reportlinker Adds Cell Therapy - Technologies, Markets and Companies 11Reportlinker Adds Cell Therapy - Technologies, Markets and Companies 12Reportlinker Adds Cell Therapy - Technologies, Markets and Companies 13Reportlinker Adds Cell Therapy - Technologies, Markets and Companies 14Reportlinker Adds Cell Therapy - Technologies, Markets and Companies 15Reportlinker Adds Cell Therapy - Technologies, Markets and Companies 16Reportlinker Adds Cell Therapy - Technologies, Markets and Companies 17Reportlinker Adds Cell Therapy - Technologies, Markets and Companies 18Reportlinker Adds Cell Therapy - Technologies, Markets and Companies 19Reportlinker Adds Cell Therapy - Technologies, Markets and Companies 20
Designed for simple operation, the Model 515B pulse oximeter is ideal for use in any clinical setting; from emergency hospital transport to continuous monitoring in Anesthesia, Intensive Care and Gen...
... Whether it's for an emergency situation, ... NPB-75 Handheld Capnograph / Pulse Oximeter delivers ... values. This portable, handheld monitor now contains ... is compatible with OxiMax sensors. The NPB-75 ...
... Nellcor Oxinet III Central Station and Paging ... level by providing earlier notification of developing ... the general care floor to provide affordable ... Oxinet III system features a central station ...
... Oximeter with Oxismart XL Advanced Signal Processing ... nonspecific noise to find the pulse and ... rate values. , ,The N395 monitor ... a breakthrough in clinician-programmable alarm sensitivity for ...
Medicine Products: